Phibro Animal Health PAHC
NASDAQ PAHC
$37.24 +1.37 (+3.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Phibro Animal Health (PAHC) Non Operating Interest Expenses (2013 - 2026)

Updated

Phibro Animal Health (PAHC) recorded Non Operating Interest Expenses of $10.71 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 18.6% from $9.03 million a year earlier and up 0.3% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Non Operating Interest Expenses (2013 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Phibro Animal Health reported Non Operating Interest Expenses of $46.42 million, up 24.7% from FY2025.

  • Annual Non Operating Interest Expenses has increased for four straight fiscal years, with a four-year compound annual growth rate of 38.3% (FY2022 to FY2026).
  • Across earlier fiscal years, Non Operating Interest Expenses came in at $37.22 million in FY2025 (+61.8%), $23.01 million in FY2024 (+23.2%), $18.68 million in FY2023 (+47.2%) and $12.69 million in FY2022.
  • Quarterly Non Operating Interest Expenses has ranged from $5.65 million in fiscal Q1 2024 to $12.54 million in fiscal Q1 2026 over the past five years.
  • On a year-over-year basis, Non Operating Interest Expenses has increased for eight consecutive quarters, with growth averaging 43.5% over the last eight quarters.
  • Across the past five years, year-over-year growth in Non Operating Interest Expenses ran from 10.6% in fiscal Q3 2026 to 71.0% in fiscal Q3 2025.
  • Per Business Quant, the preceding three fiscal quarters came in at $10.68 million (Q3 2026), $12.48 million (Q2 2026) and $12.54 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Phibro Animal Health 1.45 Bn 1.13 Bn 134.40 Mn 10.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.71 Mn
Mar 31, 2026 10.68 Mn
Dec 31, 2025 12.48 Mn
Sep 30, 2025 12.54 Mn
Jun 30, 2025 9.03 Mn
Mar 31, 2025 9.65 Mn
Dec 31, 2024 9.78 Mn
Sep 30, 2024 8.77 Mn
Jun 30, 2024 6.00 Mn
Mar 31, 2024 5.65 Mn
Dec 31, 2023 5.72 Mn
Sep 30, 2023 5.65 Mn
Jun 30, 2015 3.79 Mn
Mar 31, 2015 3.66 Mn
Dec 31, 2014 3.55 Mn
Sep 30, 2014 3.55 Mn
Jun 30, 2014 6.53 Mn
Mar 31, 2014 7.81 Mn
Dec 31, 2013 7.78 Mn
Sep 30, 2013 7.77 Mn
API Access

Phibro Animal Health Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=PAHC&period=max&api_key=YOUR_API_KEY